Investment
Features
FeesSafety
Academy
More
Pluang+

Nordea Investment Management doubles stake in Regeneron Pharmaceuticals to 137,321 shares worth $105.8M.

Market News
23 Mar 2026
Defense World
View Source
Bullish
pluang ai news

Nordea Investment Management AB increased its holdings in Regeneron Pharmaceuticals by 118.1% in Q4, acquiring an additional 74,350 shares for a total of 137,321 shares valued at $105.8 million. This move reflects growing institutional confidence in Regeneron, a biopharmaceutical company known for its innovative drug development. Analysts maintain a generally positive outlook, with price targets rising and a consensus rating of "Moderate Buy." Regeneron also recently raised its quarterly dividend, signaling financial strength and shareholder value focus.

More News (REGN)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App